In addition to their primary function as antibiotics, microbial secondary metabolites are essential to modern biological technology and medicine. Throughout the idiophase, bacteria, fungi, and plants produce these biologically active substances, which are necessary for avoiding infections while promoting advanced healthcare procedures such as cancer treatments and certain surgeries. Secondary metabolic products can be described as either bacteriostatic, which prevents bacterial growth by interacting with protein synthesis or folate production, or bactericidal, which damages cell wall integrity and vital cellular functions. The ability of these systems to change is an important factor in the fight against antimicrobial resistance (AMR), which has become an increasing concern for global health, sustainability, food security, and healthcare systems. The overuse of antimicrobials in both agriculture and human health contributes to the growing challenge of AMR, so to combat this challenge, we need to think of new and better solutions. Recent developments in genomic data science, high-resolution mass spectrometry, and elucidation of biochemical pathways are helping to identify new secondary metabolite compounds that may be clinically useful in the treatment of multidrug-resistant infections. This review provides a thorough understanding of how secondary metabolites develop, what they do, and what they are contributing to our efforts to combat AMR by providing increased support for both the development of sustainable practices and the creation of novel methods for drug discovery to fight against antibiotic resistance.